WallStreetZenWallStreetZen

NASDAQ: BMRN
Biomarin Pharmaceutical Inc Stock Ownership - Who owns Biomarin Pharmaceutical?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Biomarin Pharmaceutical Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Cristin HubbardEVP Chief Commercial Officer2025-05-202,155$59.93
$129.15kSell
Erin BurkhartGVP Chief Accounting Officer2025-05-201,786$59.31
$105.93kSell
Erin BurkhartGVP Chief Accounting Officer2025-05-19996$59.27
$59.03kSell
Cristin HubbardEVP Chief Commercial Officer2025-05-02273$64.92
$17.72kSell
Cristin HubbardEVP Chief Commercial Officer2025-04-30273$54.14
$14.78kBuy
Erin BurkhartGVP Chief Accounting Officer2025-03-191,295$71.52
$92.62kSell
Charles Greg GuyerEVP Chief Technical Officer2025-03-1420,127$69.44
$1.40MSell
Brian MuellerEVP Chief Financial Officer2025-03-1418,497$69.44
$1.28MSell
Erin BurkhartGVP Chief Accounting Officer2025-03-14823$69.44
$57.15kSell
George Eric DavisEVP Chief Legal Officer2025-03-1416,249$69.44
$1.13MSell

1 of 2

BMRN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BMRN insiders and whales buy or sell their stock.

BMRN Shareholders

What type of owners hold Biomarin Pharmaceutical Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc12.40%23,778,999$1.40BInstitution
Vanguard Group Inc9.91%19,003,212$1.12BInstitution
Primecap Management Co9.27%17,773,281$1.05BInstitution
Dodge Cox7.80%14,955,240$879.67MInstitution
Viking Global Investors LP5.63%10,800,059$635.26MInstitution
Capital Research Global Investors4.77%9,150,655$538.24MInstitution
State Street Corp4.41%8,463,090$497.80MInstitution
Ameriprise Financial Inc2.19%4,207,563$247.49MInstitution
Elliott Investment Management LP1.83%3,500,338$205.89MInstitution
Geode Capital Management LLC1.79%3,431,253$201.83MInstitution

1 of 3

BMRN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BMRN95.21%1.74%Net SellingNet Selling
ASND100.00%0.00%
EXEL92.11%5.25%Net SellingNet Selling
MRNA72.07%22.78%Net BuyingNet Selling
INCY76.72%23.28%Net SellingNet Selling
View Top Biotech Stocks

Biomarin Pharmaceutical Stock Ownership FAQ

Who owns Biomarin Pharmaceutical?

Biomarin Pharmaceutical (NASDAQ: BMRN) is owned by 95.21% institutional shareholders, 1.74% Biomarin Pharmaceutical insiders, and 3.05% retail investors. Blackrock Inc is the largest individual Biomarin Pharmaceutical shareholder, owning 23.78M shares representing 12.40% of the company. Blackrock Inc's Biomarin Pharmaceutical shares are currently valued at $1.38B.

If you're new to stock investing, here's how to buy Biomarin Pharmaceutical stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.